[The efficacy of Macronil in treating acute respiratory infections in children 0 to 5 years old].
The authors followed the efficiency of product Macronil in association with the usual (antibiotic and symptomatic) treatments in acute, viral respiratory infections in 62 children, 0-5 years old, admitted into hospital. Besides the usual treatment (25 cases--control group) Macronil was administered in 37 cases (experimental group). A significant improvement was found in clinical evolution (duration of disease evolution, improvement of general state, good appetite, fever duration, increase in weight) of the experimental group versus the control group. An important reduction (twice) of the pharyngeal viral population appeared in the experimental group treated with Macronil. In the control group, the viral flora, remained, practically, the same after treatment.